Baron Funds reported a 5.06% decline for their Baron Health Care Fund in Q2 2025, against a challenging backdrop for the Health Care sector. The fund’s top five holdings can be found in their investor letter.

Edwards Lifesciences Corporation (NYSE:EW) saw a one-month return of 5.69% and a 31.20% gain over the last 52 weeks. The stock closed at $81.16 per share on July 30, 2025, with a market cap of $47.608 billion.

Baron Health Care Fund highlighted Edwards Lifesciences Corporation (NYSE:EW) in its Q2 2025 letter, citing TAVR as a growing market. Edwards Lifesciences is well-positioned in this field with a strong clinical background and market opportunity due to competitors exiting the market.

Edwards Lifesciences Corporation (NYSE:EW) reported total sales of $1.53 billion in Q2 2025, reflecting a 10.6% growth. While considered a good investment, other AI stocks may offer greater potential. Additionally, 63 hedge funds held positions in Edwards Lifesciences Corporation (NYSE:EW) at the end of the first quarter.

Jim Cramer shared positive thoughts on Edwards Lifesciences Corporation (NYSE:EW) in a recent article. For more insights on investor letters and hedge fund activity, visit the provided links for additional information.

Read more at Yahoo Finance: Baron Health Care Fund Reacquired Edwards Lifesciences Corporation (EW) in Q2. Here’s Why